Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Grassroots Cannabis, officially known as GR Companies Inc., is a leading vertically integrated multi-state cannabis operator in the United States. The company focuses on the cultivation, processing, and dispensing of premium cannabis products for both medical and adult-use markets. Its product portfolio includes a wide range of delivery forms such as flower, concentrates, vapes, and edibles, designed to address various therapeutic needs including chronic pain and neurological disorders. In July 2020, Grassroots was acquired by Curaleaf Holdings for approximately $830 million, significantly expanding Curaleaf's presence across the Midwest and Northeast regions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Grassroots Brands.